Table of Contents
IDC FutureScape Figure
Figure: IDC FutureScape: Worldwide Life Sciences 2022 Top 10 Predictions
Executive Summary
IDC FutureScape Predictions
Summary of External Drivers
Predictions: Impact on Technology Buyers
Prediction 1: By 2023, 75% of Life Sciences Manufacturers Will Invest in Intelligent Supply Chain Solutions to Enable Resilience and Prevent Future Disruptions During Health Emergencies Such as COVID-19
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 2: By 2024, AI Investments in In Silico Drug Discovery Will Double to Fuel Growth of Genomics and Precision Medicine to Bring Vital Vaccines and Medicines to Patients Faster
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 3: By 2025, 75% of Trials Will Be Patient-Centric Decentralized Clinical Trials; 90% Will Be Hybrid and at Least 10% Will Be Virtual, Driven by 30% Growth in Connected Health Technologies
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 4: By 2025, the Market for Prescription Digital Therapeutics Will More Than Triple, Led by Mental Health and Chronic Conditions, Blurring the Boundaries Between Healthcare and Life Sciences
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 5: Investment in AI for Real-World Evidence by Life Sciences Companies Will Double by 2025, Driven by Health Data Interoperability Initiatives and Platforms
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 6: By 2026, Two-Thirds of Life Sciences Companies Will Adopt the Intelligent Lab of the Future Leveraging Digital Transformation, Integrating the Internet of Lab Things
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 7: By 2026, the Increased Adoption of Medication Adherence Apps, Smart IoT–Based Solutions, and Connected Drug Delivery Systems Will Reduce Treatment Compliance Gaps in Clinical Trials by One-Third
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 8: The Use of Digital Twins in Manufacturing and Supply Chain Planning at Multinational Life Sciences Firms Will Double by 2026, with Deeper Adoption in R&D Coming Later
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 9: Triggered by COVID-19, Half of New Business Value Created in the Global Life Sciences Market by 2026 Will Be Driven by Cloud-Based Digital Ecosystems and Federated Learning, Powering R&D Co-Innovation
Associated Drivers
IT Impact
Patient Impact
Guidance
Prediction 10: Integrated Research Organizations Will Double in Number by 2027, Fueling the Adoption of Clinical Research as a Care Option Within the Healthcare Ecosystem
Associated Drivers
IT Impact
Patient Impact
Guidance
Advice for Technology Buyers
External Drivers: Detail
Pervasive Disruption Continues — Volatility, Opportunity, and Resilience
Cybersecurity and Risk — The Threat Environment Just Keeps Scaling
The Future Enterprise — Thriving in a Jungle of Agile Innovation
Embracing Digital First — New Strategies for Complexity and Ubiquity
Digital Ecosystem — Thriving in a Multiplatform World
Workforce Outlook — Redefining Teams, Reinventing Models, and Rethinking Leadership
Engagement Reimagined — From Responsive to Anticipatory
Learn More
Related Research